144 related articles for article (PubMed ID: 2496130)
1. Combined host and specific anti-Pseudomonas-directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretic considerations.
Holder IA; Neely AN
J Burn Care Rehabil; 1989; 10(2):131-7. PubMed ID: 2496130
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
Holder IA
Can J Microbiol; 1985 Apr; 31(4):393-402. PubMed ID: 3924388
[No Abstract] [Full Text] [Related]
3. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
Wretlind B; Pavlovskis OR
Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
[TBL] [Abstract][Full Text] [Related]
4. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy.
Stanislavsky ES; Dmitriev BA; Lányi B; Joó I
Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389
[No Abstract] [Full Text] [Related]
5. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
Antibiot Chemother (1971); 1987; 39():222-32. PubMed ID: 3118784
[No Abstract] [Full Text] [Related]
6. Protective activity of anti-exotoxin A monoclonal antibody against mice infected with toxin-producing Pseudomonas aeruginosa.
Kohzuki T; Eguchi Y; Kato M; Irie K; Ohtsuka H; Higuchi A; Noguchi H
J Infect Dis; 1993 Jan; 167(1):119-25. PubMed ID: 8418158
[TBL] [Abstract][Full Text] [Related]
7. Anti-ETA IgG neutralizes the effects of Pseudomonas aeruginosa exotoxin A.
Fogle MR; Griswold JA; Oliver JW; Hamood AN
J Surg Res; 2002 Jul; 106(1):86-98. PubMed ID: 12127813
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas. Clinical problems related to virulence factors and development of resistance.
Nordbring F
Arch Intern Med; 1982 Oct; 142(11):2010-1. PubMed ID: 6812525
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.
Woods DE; Schaffer MS; Rabin HR; Campbell GD; Sokol PA
J Clin Microbiol; 1986 Aug; 24(2):260-4. PubMed ID: 3018037
[TBL] [Abstract][Full Text] [Related]
10. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
[TBL] [Abstract][Full Text] [Related]
11. Role of exotoxin A and elastase in the pathogenicity of Pseudomonas aeruginosa strain PAO experimental mouse burn infection.
Wretlind B; Björklind A; Pavlovskis OR
Microb Pathog; 1987 Jun; 2(6):397-404. PubMed ID: 3148812
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors.
Cash HA; Straus DC; Bass JA
Can J Microbiol; 1983 Apr; 29(4):448-56. PubMed ID: 6406026
[TBL] [Abstract][Full Text] [Related]
13. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa.
Nicas TI; Iglewski BH
J Clin Microbiol; 1986 May; 23(5):967-9. PubMed ID: 3086372
[TBL] [Abstract][Full Text] [Related]
14. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
[TBL] [Abstract][Full Text] [Related]
15. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
Nicas TI; Iglewski BH
Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
Lory S; Tai PC
Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071
[No Abstract] [Full Text] [Related]
17. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
O'Callaghan RJ; Engel LS; Hobden JA; Callegan MC; Green LC; Hill JM
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):534-43. PubMed ID: 8595953
[TBL] [Abstract][Full Text] [Related]
18. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection.
Sharma S; Kaur R; Yadav V; Harjai K; Joshi K
Jpn J Infect Dis; 2004 Jun; 57(3):119-20. PubMed ID: 15218223
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of Pseudomonas aeruginosa infections in leukopenic mice by a combination of active and passive immunization.
Martinez D; Callahan LT
Eur J Clin Microbiol; 1985 Apr; 4(2):186-9. PubMed ID: 3924606
[TBL] [Abstract][Full Text] [Related]
20. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.
Pitt TL
J R Soc Med; 1986; 79 Suppl 12(Suppl 12):13-8. PubMed ID: 2425090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
